Michael Wermann

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• University of British Columbia11.7%
• Probiodrug (Germany)11.5%
• Bristol-Myers Squibb (United States)8.5%
• LMU Klinikum8%
• Merck & Co., Inc., Rahway, NJ, USA (United States)7.4%
• Tongji University6.9%
• Other46%

Fields

• Medicine67.4%
• Biochemistry, Genetics and Molecular Biology18.6%
• Immunology and Microbiology6.6%
• Neuroscience2.7%
• Nursing1.9%
• Computer Science1.6%
• Other1.2%

Topics

• Peptidase Inhibition and Analysis24.6%
• Diabetes Treatment and Management16.6%
• Neuropeptides and Animal Physiology16.6%
• Alzheimer's disease research and treatments9.1%
• Protein Hydrolysis and Bioactive Peptides5.3%
• Pancreatic function and diabetes4.7%
• Other23.1%